akampion News

Please click here to subscribe to regular news updates from the akampioneer.com
Friday, July 1, 2016

Company News: Curetis Announces Participation in Clinical, Scientific and Investor Meetings in the Third Quarter 2016

Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced its participation in major scientific and investor meetings in the third quarter of 2016.

 

July-August:

AACC Annual Meeting & Clinical Lab Expo 2016, July 31 – August 04, 2016, in Philadelphia, PA, USA. Exhibition booth no. 135.

 

September:

35th Annual Meeting of the European Bone & Joint Infections Society, September 1-3, 2016, in Oxford, UK.  Exhibition booth no. E05. Joint meeting with Curetis´ partner Heraeus Medical.

68th Annual Meeting of the German Society for Hygiene and Microbiology (DGHM), September 11-14, 2016, in Ulm, Germany. Exhibition booth details to be confirmed. In addition, Curetis will host a Lunch Symposium.

Tuesday, June 28, 2016

Company News: Curetis Completes Sample Enrollment in Unyvero U.S. FDA Trial in Lower Respiratory Tract Infections

- Last patient enrolled in prospective arm of IVD trial

- More than 2,250 prospective and retrospective samples enrolled in study

- Data to be complemented with up to 500 additional contrived samples with focus on rare pathogens

Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced the completion of patient enrollment in its Unyvero U.S. FDA trial. The primary endpoint of the prospective and retrospective study is the performance of the Unyvero LRT55 Lower Respiratory Tract cartridge in detecting lower respiratory tract infections as compared to microbiology culture, the current diagnostic standard of care.